FDA Law Blog
MAY 7, 2025
Two recent cases from the Fifth and Seventh Circuits, however, support the legality of these arrangements in the absence of the government proving certain circumstances. The Court explained that the unsigned prescriptions sent to physicians are best understood as proposals for care, not as referrals. Mallory , 988 F.3d 3d 730 (4th Cir.
Blood, Sweat, and Tears
MAY 24, 2022
You have to be able to laugh at situations, the system, the government, people and especially yourself (Mostly yourself). I was so burnt out, dragging my feet, lugging my head from patient to patient. She was always the first one to notice and address patient difficulties. What if another patient comes in?”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Tiny Physician
FEBRUARY 15, 2022
A few days back, a video went viral on social media in which a resident doctor (a doctor who is undergoing post-graduation / PG doctor) was shouting at the bystander of a patient. For example, a PG doctor, while examining a case, will be asked to collect blood test results from the lab and to accompany a patient for a CT scan after that.
FDA Law Blog
NOVEMBER 6, 2022
In its petition filed earlier this month, Pfizer challenges HHS’s interpretation of the AKS as “staggeringly overbroad,” contrary to the congressional intent behind the AKS, and a threat to “almost any activity that facilitates patient access to federally funded healthcare.” Borrasi, 639 F.3d 3d 774 (7th Cir.
FDA Law Blog
JANUARY 6, 2022
Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. A) to induce a referral of an individual to a recovery home, clinical treatment facility, or laboratory; or. (B)
FDA Law Blog
SEPTEMBER 29, 2021
Manufacturers may choose not to participate in this program, but the federal government will not reimburse for their outpatient drugs under Medicaid or Medicare Part B if they do not. A 2018 report by the Government Accountability Office (“GAO”) found similar issues, as well as contract pharmacy noncompliance and poor federal oversight.
FDA Law Blog
JANUARY 6, 2022
Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. A) to induce a referral of an individual to a recovery home, clinical treatment facility, or laboratory; or. (B)
Expert insights. Personalized for you.
59 
Let's personalize your content